Consequences of high-dose steroid therapy for acute spinal cord injury
Consequences of high-dose steroid therapy for acute spinal cord injury
复制标题
DOI:
10.1097/00005373-199702000-00017
复制
发表时间:
1997-02-01
影响因子:
--
通讯作者:
Papadopoulos, SM
中科院分区:
文献类型:
--
作者:
Gerndt, SJ;Rodriguez, JL;Papadopoulos, SM
Objective: High-dose Solu-Medrol (Upjohn, Kalamazoo, Mich) therapy has become standard care in the management of acute spinal cord injury (ASCI), This study attempts to define the adverse effects that Solu-Medrol therapy has on these patients.Design: Retrospective review with historical control.Material and Methods: From May 1990 to April 1994, all patients with ASCI admitted within 8 hours of injury received high-dose Solu-Medrol per the National Acute Spinal Injury Study (NASCIS-2) protocol, Their demographic and outcome parameters were compared with those of a group admitted from March 1986 to December 1993 with an associated ASCI who received no steroid therapy.Measurements and Main Results: Steroid therapy was associated with a 2.6-fold increase in the incidence of pneumonia and an increase in ventilated and intensive care days, However, it was associated with a decrease in duration of rehabilitation and had no significant impact on other outcome parameters, including mortality.Conclusions: Although the NASCIS-2 protocol may promote early infectious complications, it has no adverse impact on longterm outcome in patients with ASCIs.